150 related articles for article (PubMed ID: 582768)
1. Effects of long-term treatment with suloctidil on blood viscosity, erythrocyte deformability and total fibrinogen plasma levels in diabetic patients.
Roncucci R; De Hertogh R; Dormandy JA; Doumont J; Gurewich V; Lambelin G; Lansen J; Rottiers R; Souridis E; Van Stalle F; Versee L
Arzneimittelforschung; 1979; 29(4):682-4. PubMed ID: 582768
[TBL] [Abstract][Full Text] [Related]
2. Suloctidil: long-term trial in the aged. Study of microcirculation, viscosity, red cell deformability, fibrinolysis and lipid fractions.
Merchan R; Zurita IE; Martinez JF
Arzneimittelforschung; 1985; 35(5):855-7. PubMed ID: 2992530
[TBL] [Abstract][Full Text] [Related]
3. [Hemorrheological survey in a group with arteriosclerotic vascular disease treated with suloctidil].
Caimi G; Catania A; Frazzetta F; Capobianco D; Francavilla G; Romano A; Sarno A
Ric Clin Lab; 1983; 13 Suppl 3():465-8. PubMed ID: 6324326
[TBL] [Abstract][Full Text] [Related]
4. [Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability].
Pilla G; Ciaponi A; Migliavacca A; Bonora C
Ric Clin Lab; 1983; 13 Suppl 3():459-64. PubMed ID: 6324325
[TBL] [Abstract][Full Text] [Related]
5. [Blood viscosity and erythrocyte deformability in diabetic retinopathy].
Melli M; Poggi M; Codeluppi L; Baraldi P; Torlai F; Peduzzi M
Ric Clin Lab; 1983; 13 Suppl 3():371-4. PubMed ID: 6673016
[TBL] [Abstract][Full Text] [Related]
6. Activation of platelets and of fibrinolysis by venous occlusion in healthy volunteers and influence of suloctidil in comparison with placebo.
Baele G; Bary JL; van Stalle F
Arzneimittelforschung; 1983; 33(8):1203-5. PubMed ID: 6315025
[TBL] [Abstract][Full Text] [Related]
7. The relationship of plasma fibrinogen, erythrocyte flexibility and blood viscosity.
Dupont PA; Sirs JA
Thromb Haemost; 1977 Oct; 38(3):660-7. PubMed ID: 579511
[TBL] [Abstract][Full Text] [Related]
8. Haemorheological disturbances in hypertensive type 2 diabetic patients--influence of antihypertensive therapy.
Kearney-Schwartz A; Virion JM; Stoltz JF; Drouin P; Zannad F
Fundam Clin Pharmacol; 2007 Aug; 21(4):387-96. PubMed ID: 17635177
[TBL] [Abstract][Full Text] [Related]
9. Chronic hemorheological effects of the calcium antagonist nilvadipine in essential hypertension.
Tsuda Y; Satoh K; Kitadai M; Izumi Y; Takahashi T
Arzneimittelforschung; 1997 Aug; 47(8):900-4. PubMed ID: 9296274
[TBL] [Abstract][Full Text] [Related]
10. Double-blind trial of suloctidil versus placebo in moderate to severe mental deterioration.
Baro F; Malfroid M; Waegemans T; Cox JP
Pharmatherapeutica; 1985; 4(6):399-404. PubMed ID: 3001778
[TBL] [Abstract][Full Text] [Related]
11. [Hemorheologic parameters in patients with giant cell arteritis before and after treatment with steroids].
Wiek J; Krause M; Wiederholt M; Hansen LL
Fortschr Ophthalmol; 1990; 87(6):671-4. PubMed ID: 2086417
[TBL] [Abstract][Full Text] [Related]
12. Rheological changes in diabetic microangiopathy.
Negrean V; Suciu I; Sâmpelean D; Cozma A
Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
[TBL] [Abstract][Full Text] [Related]
13. Red blood cell deformability in diabetes mellitus: effect of phytomenadione.
Sabo A; Jakovljević V; Stanulović M; Lepsanović L; Pejin D
Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):1-5. PubMed ID: 8444511
[TBL] [Abstract][Full Text] [Related]
14. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.
Toth K; Kesmarky G; Vekasi J; Nemes J; Czopf L; Kapronczay P; Halmosi R; Papp E; Juricskay I
Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745
[TBL] [Abstract][Full Text] [Related]
15. Pentoxifylline attenuates the increase in whole blood viscosity after transfusion.
Bacher A; Eggensperger E; Koppensteiner R; Mayer N; Klimscha W
Acta Anaesthesiol Scand; 2005 Jan; 49(1):41-6. PubMed ID: 15675980
[TBL] [Abstract][Full Text] [Related]
16. Effects of Chinese medicinal herbs on hemorheology in diabetics.
Liang XC; Guo SS; Qian ZF; Hong G; Tao LH; Wang Y; Zhu SY
Proc Chin Acad Med Sci Peking Union Med Coll; 1989; 4(3):135-8. PubMed ID: 2594735
[TBL] [Abstract][Full Text] [Related]
17. Clinical and biological activity of the antiplatelet agent suloctidil in treatment of idiopathic recurrent vein thrombosis (I.R.V.T.).
Moriau M; Col-De Beys C; Pardonge E; Ferrant A
Thromb Haemost; 1982 Feb; 47(1):27-31. PubMed ID: 6280332
[TBL] [Abstract][Full Text] [Related]
18. [Blood viscosity and related factors in patients with primary open-angle glaucoma].
Wu ZJ; Li MY
Zhonghua Yan Ke Za Zhi; 1993 Nov; 29(6):353-5. PubMed ID: 8020379
[TBL] [Abstract][Full Text] [Related]
19. [Effect of prostacyclin on erythrocyte deformability and blood viscosity].
Galanti G; Paoli G; Albanese B; Manescalchi PG
Ric Clin Lab; 1983; 13 Suppl 3():445-50. PubMed ID: 6369495
[TBL] [Abstract][Full Text] [Related]
20. Influence of propofol on erythrocyte morphology, blood viscosity and platelet function.
Reinhart WH; Felix Ch
Clin Hemorheol Microcirc; 2003; 29(1):33-40. PubMed ID: 14561902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
